StockWatch
·
Pharmaceuticals
Quarterly Result14 May 2026, 05:51 pm

Sanjivani Paranteral Approves Audited Results for FY26

AI Summary

Sanjivani Paranteral Ltd. announced the approval of audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026, during its board meeting held on May 14, 2026. The audit report, conducted by R. B. Gohil & Co., Chartered Accountants, expresses an unqualified opinion on the financial results, stating they present a true and fair view in accordance with applicable accounting standards and Listing Regulations.

Key Highlights

  • Audited standalone and consolidated financial results for FY26 approved.
  • Board meeting held on May 14, 2026, to approve the results.
  • R. B. Gohil & Co. issued an unqualified audit opinion.
  • Financial results comply with Regulation 33 of Listing Regulations.
  • Meeting commenced at 04:00 P.M. and concluded at 05:30 P.M.